Download our whitepaper,

Neuropathic Pain Clinical Trials:
Advanced Treatment Strategies

What's Inside:

  • Understanding neuropathic pain mechanisms and clinical presentations.
  • Optimal endpoint selection for neuropathic pain trials.
  • Patient-reported outcomes and quality of life assessments.
  • Safety monitoring protocols for novel analgesic therapies.
  • Regulatory considerations for pain management trials.
  • Case studies of successful neuropathic pain trial designs.

Access your complimentary whitepaper today:






    Neuropathic Pain Clinical Trials

    Neuropathic pain arises from damage or dysfunction of the nervous system, leading to chronic pain conditions that significantly impact patients’ quality of life. Clinical trials in this area focus on evaluating the efficacy and safety of novel analgesics and treatment strategies.

    Over the years, advancements in understanding the pathophysiology of neuropathic pain have informed the development of targeted therapies. Clinical trial designs have evolved to incorporate patient-reported outcomes, biomarker assessments, and adaptive methodologies to enhance trial success.

    iNGENū’s expertise in neuropathic pain clinical trials enables us to design and execute studies that address the unique challenges of this field. By leveraging our deep understanding of pain mechanisms and regulatory requirements, we aim to accelerate the development of effective treatments for patients suffering from neuropathic pain.

    Approximately

    7-10%

    of the general population suffers from neuropathic pain

    Neuropathic pain accounts for about

    20-30%

    of chronic pain cases seen in clinical practice

    Clinical trials in neuropathic pain have a success rate of around

    15-20%

    reflecting the complexity of pain mechanisms

    iNGENū’s clinical team has over

    120 years

    of combined clinical trial experience